Efficacy and Safety of Clifutinib, a Novel, Highly Selective, Oral FLT3 Inhibitor, in Patients with FLT3-Mutated Relapsed or Refractory Acute Myeloid Leukemia:Updated Results from a Phase I StudyJie Jin,Huafeng Wang,Wen-Juan Yu,Zheng Ge,Xudong Wei,Yuhua Li,Zhongxing Jiang,Yiqing Li,Xin Du,Linhua Yang,Lie Lin,Jishi Wang,Yazhou Yao, Xiaoping Hu,Jianping Lan,Xiuzhi Deng,Tong Chen,Xianqi Feng,Dengju Li,Ming Hou,Rong Fu, Siyong Huang, Jingbo Wang,Xin Du,Hui Yang,Haiping Yang,Yingzhi Jiang,Zhijie Wang, Deng Li, Bing Liu,Ning Kang,Yulei Zhuang,Yingjun ZhangBLOOD（2023）引用 0|浏览7暂无评分关键词Acute myeloid leukemia,FLT3 inhibitor,ClifutinibAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
